Avivagen Inc.
VIVXF
$0.00
$0.000.00%
OTC PK
07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
---|---|---|---|---|---|
Net Income | 32.23% | 8.07% | 18.37% | 7.22% | -9.71% |
Total Depreciation and Amortization | -39.47% | -30.64% | -33.58% | -31.35% | -26.05% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 15.60% | 8.69% | -40.52% | -26.95% | -31.12% |
Change in Net Operating Assets | 90.30% | 334.88% | 221.22% | 201.46% | 180.91% |
Cash from Operations | 81.55% | 47.37% | 42.06% | 34.73% | 11.91% |
Capital Expenditure | -- | -- | -- | -- | 135.71% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | 135.71% |
Total Debt Issued | -100.00% | -199.70% | -100.00% | -100.00% | -98.52% |
Total Debt Repaid | 99.17% | 89.30% | -377.45% | -386.21% | -418.38% |
Issuance of Common Stock | -90.48% | 53.28% | -3.17% | -3.17% | -11.82% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -152.86% | 226.07% | 158.46% | 154.24% | 148.17% |
Cash from Financing | -81.00% | -35.32% | -60.25% | -63.27% | -78.36% |
Foreign Exchange rate Adjustments | -101.93% | -85.45% | -93.42% | -113.50% | 113.40% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 81.58% | 50.33% | -339.43% | -252.30% | -242.78% |